[HTML][HTML] Epithelial mesenchymal transition in embryonic development, tissue repair and cancer: a comprehensive overview
DH Kim, T Xing, Z Yang, R Dudek, Q Lu… - Journal of clinical …, 2017 - mdpi.com
The epithelial mesenchymal transition (EMT) plays a central role in both normal
physiological events (eg, embryonic development) and abnormal pathological events (eg …
physiological events (eg, embryonic development) and abnormal pathological events (eg …
Glioblastoma: Current status, emerging targets, and recent advances
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …
population of genetically unstable and highly infiltrative cells that are resistant to …
[PDF][PDF] Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
O Marin-Bejar, A Rogiers, M Dewaele, J Femel… - Cancer Cell, 2021 - cell.com
Therapy resistance arises from heterogeneous drug-tolerant persister cells or minimal
residual disease (MRD) through genetic and nongenetic mechanisms. A key question is …
residual disease (MRD) through genetic and nongenetic mechanisms. A key question is …
[HTML][HTML] Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for
preclinical studies and therapeutic testing. It has been proposed that the mouse host affects …
preclinical studies and therapeutic testing. It has been proposed that the mouse host affects …
[HTML][HTML] Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery
Co-fractionation/mass spectrometry (CF/MS) enables the mapping of endogenous
macromolecular networks on a proteome scale, but current methods are experimentally …
macromolecular networks on a proteome scale, but current methods are experimentally …
[HTML][HTML] Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment
X Wu, J Wang, Q Liang, R Tong, J Huang… - Biomedicine & …, 2022 - Elsevier
Focal adhesion kinase (FAK, also known as PTK2) is a tyrosine kinase that regulates
integrin and growth factor signaling pathways and is involved in the migration, proliferation …
integrin and growth factor signaling pathways and is involved in the migration, proliferation …
Progress in the development of small molecular inhibitors of focal adhesion kinase (FAK)
Y Lu, H Sun - Journal of Medicinal Chemistry, 2020 - ACS Publications
Focal adhesion kinase (FAK) is a nonreceptor intracellular tyrosine kinase that plays an
essential role in cancer cell adhesion, survival, proliferation, and migration through both its …
essential role in cancer cell adhesion, survival, proliferation, and migration through both its …
[HTML][HTML] Cancer stem cell targeted therapy: progress amid controversies
Although cancer stem cells have been well characterized in numerous malignancies, the
fundamental characteristics of this group of cells, however, have been challenged by some …
fundamental characteristics of this group of cells, however, have been challenged by some …
[HTML][HTML] Drug discovery targeting focal adhesion kinase (FAK) as a promising cancer therapy
XJ Pang, XJ Liu, Y Liu, WB Liu, YR Li, GX Yu, XY Tian… - Molecules, 2021 - mdpi.com
FAK is a nonreceptor intracellular tyrosine kinase which plays an important biological
function. Many studies have found that FAK is overexpressed in many human cancer cell …
function. Many studies have found that FAK is overexpressed in many human cancer cell …
Nobiletin as an inducer of programmed cell death in cancer: a review
J Huang, Z Chang, Q Lu, X Chen, M Najafi - Apoptosis, 2022 - Springer
Cancer resistance to therapy is a big issue in cancer therapy. Tumours may develop some
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …